BRG1: Promoter or Suppressor of Cancer? The Outcome of BRG1’s Interaction with Specific Cellular Pathways
BRG1 is one of two catalytic subunits of the SWI/SNF ATP-dependent chromatin-remodeling complex. In cancer, it has been hypothesized that BRG1 acts as a tumor suppressor. Further study has shown that, under certain circumstances, BRG1 acts as an oncogene. Targeted knockout of BRG1 has proven success...
Main Authors: | Aaron Shaykevich, Isaac Silverman, Gargi Bandyopadhyaya, Radhashree Maitra |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/3/2869 |
Similar Items
-
Case Report: SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder with genetic analysis
by: Xiangpeng Meng, et al.
Published: (2023-06-01) -
TTF1-positive SMARCA4/BRG1 deficient lung adenocarcinoma
by: Anurag Mehta, et al.
Published: (2022-01-01) -
Super-Enhancer Dysregulation in Rhabdoid Tumor Cells Is Regulated by the SWI/SNF ATPase BRG1
by: Cheyenne A. Jones, et al.
Published: (2024-02-01) -
Neuronal activity-induced BRG1 phosphorylation regulates enhancer activation
by: BongWoo Kim, et al.
Published: (2021-07-01) -
On the Interaction Between SMARCAL1 and BRG1
by: Deepa Bisht, et al.
Published: (2022-06-01)